World‑Renowned Dalhousie Bioethicist and Battery Pioneer Win Prestigious Killam Prize
By Andrew Riley and Caitlyn MacDonald,
Dal News
| 03. 15. 2022
Françoise Baylis, photo by XhenetaM,
CC BY-SA 4.0, via Wikimedia Commons
Two of Dalhousie’s leading researchers are being honoured with the $100,000 Killam Prize, winning two of the five prestigious awards granted annually by the Killam Trusts.
On Tuesday morning, the Canada Council for the Arts announced Françoise Baylis and Jeff Dahn as 2022 recipients of the honour. Offered to Canadian scholars who have distinguished themselves through sustained distinction and impact in their fields, the Killam Prize is considered the top national award of research excellence.
“It is a historic achievement for our university to have two Killam Prize winners in one year. Drs. Baylis and Dahn are known internationally for advancing knowledge in their fields – areas that promise to shape the way we live in the future,” says Deep Saini, Dalhousie’s president and vice-chancellor.
Drs. Baylis and Dahn are only the fifth and sixth Dalhousie faculty members to receive a Killam Prize since the awards were created in 1981. Biology’s Brian Hall (2005), Philosophy’s Susan Sherwin (2006), Chemistry's Axel Becke (2016), and Medicine's Ford Doolittle (2017)...
Related Articles
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Charlie Warzel and Hana Kiros, The Atlantic | 06.24.2025
Image "Elon Musk" by Debbie Rowe on Wikimedia Commons licensed under CC by S.A. 3.0
In April, Ezibon Khamis was dispatched to Akobo, South Sudan, to document the horrors as humanitarian services collapsed in the middle of a cholera outbreak. As...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...